PAULA HOYOS: Open Payments
NPI 1003494097 · SAN CLEMENTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,136 in 105 payments from 23 companies in 2025. Trend: 2023 $2,722 · 2024 $4,093 · 2025 $4,136
Food & beverage: $4,127Travel & lodging: $9
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $655 |
| Janssen Biotech, Inc. | 10 | $442 |
| Galderma Laboratories, L.P. | 7 | $399 |
| Arcutis Biotherapeutics, Inc. | 6 | $310 |
| PFIZER INC. | 5 | $276 |
| Journey Medical Corporation | 3 | $235 |
| Lilly USA, LLC | 10 | $208 |
| UCB, Inc. | 3 | $199 |
| E.R. Squibb & Sons, L.L.C. | 4 | $187 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $173 |
Products named: DUPIXENT, TREMFYA, Zoryve, NEMLUVIO, Bimzelx, Sotyktu, AKLIEF, OPZELURA.
Industry payments across CA — which companies pay providers there.
